Early detection of cisplatin ototoxicity selected case reports

Cancer

Volumn 53, Issue 2, 1984, Pages 224-231

  Fausti, Stephen A ^a   Schechter, Martin A ^a   Rappaport, Bruce Z ^a   Frey, Richard H ^a   Mass, Robert E ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADVERSE DRUG REACTION; AUDIOMETRY; AUDITORY SYSTEM; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COCHLEA; DIAGNOSIS; DIATHERMY; DRUG THERAPY; HEAD AND NECK CANCER; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; OTOTOXICITY; THERAPY; UROGENITAL TRACT CANCER; UROGENITAL TRACT TUMOR;

AUDIOMETRY; AUDITORY THRESHOLD; CARCINOMA, SQUAMOUS CELL; CISPLATIN; HEAD AND NECK NEOPLASMS; HEARING DISORDERS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0021356307     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19840115)53:2<224::AID-CNCR2820530207>3.0.CO;2-D     Document Type: Article

References (35)

1. The role of cis‐platinum in solid tumor therapy
2. Clinical trials of cis‐diaminedichloroplatinum (NSC‐119875)
3. Cis‐diamminedichloroplatinum (NCS‐119875): A phase I study
4. Multimodal treatment of advanced testicular tumor with radical reduction surgery and multisequential chemotherapy with cis‐platinum, bleomycin, vinblastine, vincristine, and actinomycin‐D
5. Treatment of advanced bladder cancer with cis‐diaminedichloroplatinum: A pilot study
6. Cis‐dichlorodiamineplatinum (II) for the treatment of advanced ovarian cancer
7. High‐dose cis‐diaminedichloroplatinum therapy in patients with advanced breast cancer: Pharmacokinetics, toxicity, and therapeutic efficacy
8. Cis‐Dichlorodiamineplatinum and Adriamycin therapy for advanced gynecology and genitourinary neoplasms
9. Treatment of advanced carcinoma of the prostate (stage D) with infusion of cis‐diaminedichloroplatinum (II‐NSC‐119875): A pilot study
10. Treatment of genito‐urinary tumors with cis‐diaminedichloroplatinum (II): Experience in 250 patients
11. Cis‐platinum chemotherapy in head and neck cancers
12. Auditory toxicity effects of long‐term cis‐dichlorodiamineplatinum II therapy in genitourinary cancer patients
13. Ototoxocity in Patients Receiving Cisplatin: Importance of Dose and Method of Drug Administration
14. Ototoxicity of cis‐dichlorodiamineplatinum (II) in the guinea pig
15. Cis‐dichlorodiammineplatinum (II) (NSC‐119875): Hearing loss and other toxic effects in rhesus monkeys
16. Study of cis‐dichlorodiammineplatinum (II) in childhood osteosarcoma: Children's Cancer Study Group report
17. Phase II trial of cisplatin in refractory childhood cancer: Children's Cancer Study Group report
18. Cisplatin distribution in children and adolescents with cancer
19. Cis‐dichlorodiammineplatinum (NSC‐119875) in childhood malignancies
20. Phase II pharmacokinetic study of cis‐platinum diamine dichloride (CPDD) in children with solid tumors
21. Clinical response and toxicity with cis‐dichlorodiammineplatinum (II) in children
22. Phase II study of cis‐diamminedichloroplatinum (NSC‐119875) in advanced carcinoma of the large bowel
23. Cis‐platinum ototoxicity
24. Preliminary clinical experience with cis‐diamminedichloroplatinum (II) (NSC‐119875 CACP)
25. Review of the current clinical status of platinum coordination complexes in cancer chemotherapy
26. Cis‐platinum (II) diamminedichloride
27. Phase II study of cis‐dichlorodiammineplatinum (II) (NSC‐119875) in combination with cyclophosphamide (NSC‐26271) in the treatment of human malignancies
28. Phase I clinical trial of combined therapy for 5‐FU (NSC‐19893) and cis‐platinum (II) diamminedichloride (NSC‐119875)
29. Effect of absence of cochlear outer hair cells on behavioral auditory threshold
30. Ototoxic hearing loss and cochlear pathology in the monkey
31. Rappaport BZ, 2AFC versus standard clinical measurement of high‐frequency auditory sensitivity (8–20 kc/s)
32. An investigation of the validity of high‐frequency audition
33. A system for evaluating auditory function from 8000–20000 Hz
34. Preferred method for clinical determination of pure tone thresholds